Header Logo

CHRISTOPH LANGE

TitleAdjunct Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
AddressParkallee 35
Borstel, Germany, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dheda K, Lange C. Towards shorter, safer, flexible, and more effective treatment regimens for drug-resistant tuberculosis. Lancet Respir Med. 2024 Oct 01. PMID: 39366401.
      Citations:    Fields:    
    2. Loebinger MR, Aliberti S, Haworth C, Jankovic Makek M, Lange C, Lorent N, Papavasileiou A, Polverino E, Rohde G, Veziris N, Wagner D, van Ingen J. Patients at risk of nontuberculous mycobacterial pulmonary disease who need testing evaluated using a modified Delphi process by European experts. ERJ Open Res. 2024 Sep; 10(5). PMID: 39319044; PMCID: PMC11417603.
      Citations:    
    3. Donald PR, Kaufmann SHE, Schaub D, Thee S, Lange C. Carl Fl?gge, one of the last holistic hygienists and discoverer of droplet transmission of infectious diseases. Med Microbiol Immunol. 2024 Aug 02; 213(1):17. PMID: 39093331; PMCID: PMC11297070.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Cirillo D, Anthony R, Gagneux S, Horsburgh CR, Hasan R, Darboe S, Laniado-Laborin R, Probandari A, Tukvadze N, Arc?ncio RA, Bimba JS, Brighenti S, Chesov D, Chiang CY, Kalmambetova G, Knight G, Konstantynovska O, Kruse A, Lange C, Mayanja-Kizza H, McBryde E, Min J, Sanchez-Montalva A, Sulis G, Tsogt B, Van Der Walt M, Yeboah-Manu D, Hauser J. A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis. Lancet Glob Health. 2024 Aug; 12(8):e1225-e1226. PMID: 39030054.
      Citations:    Fields:    Translation:Humans
    5. Shaw ES, Stoker NG, Potter JL, Claassen H, Leslie A, Tweed CD, Chiang CY, Conradie F, Esmail H, Lange C, Pinto L, Rucsineanu O, Sloan DJ, Theron G, Tisile P, Voo TC, Warren RM, Lebina L, Lipman M. Bedaquiline: what might the future hold? Lancet Microbe. 2024 Jul 26; 100909. PMID: 39074472.
      Citations:    Fields:    
    6. Zielinski N, Baiceanu D, Dragomir A, Heyckendorf J, Ibraim E, K?hler N, Leschczyk C, Popa C, Rachow A, Sachsenweger J, Carballo PS, Schaub D, Zeeb H, Tulu B, DiNardo AR, Lange C, Reimann M, Sanchez Carballo P. A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis. Pathog Immun. 2024; 9(2):25-42. PMID: 38939039; PMCID: PMC11210591.
      Citations:    
    7. Hoelscher M, Barros-Aguirre D, Dara M, Heinrich N, Sun E, Lange C, Tiberi S, Wells C. Candidate anti-tuberculosis medicines and regimens under clinical evaluation. Clin Microbiol Infect. 2024 Sep; 30(9):1131-1138. PMID: 38909687.
      Citations:    Fields:    Translation:HumansCells
    8. Wetzstein N, Dahl VN, Lillebaek T, Lange C. Clinical spectrum and relevance of Mycobacterium malmoense: Systematic review and meta-analysis of 859 patients. J Infect. 2024 Aug; 89(2):106203. PMID: 38906266.
      Citations: 1     Fields:    Translation:HumansCells
    9. Lange C, Kherabi Y, Guglielmetti L, Duarte R, G?nther G, Tuberculosis Network European Trialsgroup, Guglielmetti L, Tuberculosis Network European Trials group. Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's response. Clin Microbiol Infect. 2024 Sep; 30(9):1207-1208. PMID: 38901496.
      Citations:    Fields:    Translation:HumansCells
    10. Otto-Knapp R, Bauer T, Brinkmann F, Feiterna-Sperling C, Friesen I, Geerdes-Fenge H, Hartmann P, Haecker B, Heyckendorf J, Kuhns M, Lange C, Maurer FP, Nienhaus A, Priwitzer M, Richter E, Salzer HJF, Schoch OD, Schoenfeld N, Schaberg T, Otto-Knapp R, Bauer T, Brinkmann F, Feiterna-Sperling C, Friesen I, Geerdes-Fenge H, Hartmann P, H?cker B, Heyckendorf J, Kuhns M, Lange C, Maurer FP, Nienhaus A, Priwitzer M, Richter E, Salzer HJF, Schoch OD, Sch?nfeld N, Schaberg T. Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland. Respiration. 2024; 103(9):593-600. PMID: 38810608; PMCID: PMC11373575.
      Citations:    Fields:    Translation:Humans
    11. Lienhardt C, Dooley KE, Nahid P, Wells C, Ryckman TS, Kendall EA, Davies G, Brigden G, Churchyard G, Cirillo DM, Di Meco E, Gopinath R, Mitnick C, Scott C, Amanullah F, Bansbach C, Boeree M, Campbell M, Conradie F, Crook A, Daley CL, Dheda K, Diacon A, Gebhard A, Hanna D, Heinrich N, Hesseling A, Holtzman D, Jachym M, Kim P, Lange C, McKenna L, Meintjes G, Ndjeka N, Nhung NV, Nyang'wa BT, Paton NI, Rao R, Rich M, Savic R, Schoeman I, Makokotlela BS, Spigelman M, Sun E, Svensson E, Tisile P, Varaine F, Vernon A, Diul MY, Kasaeva T, Zignol M, Gegia M, Mirzayev F, Schumacher SG. Target regimen profiles for tuberculosis treatment. Bull World Health Organ. 2024 Aug 01; 102(8):600-607. PMID: 39070602; PMCID: PMC11276158.
      Citations: 4     Fields:    Translation:Humans
    12. Meiwes L, Kontsevaya I, Chesov D, Kulcitkaia S, Dreyer V, Hillemann D, Dlamini Q, Williams C, Barer M, Brinkmann F, Kr?ger R, Thee S, Kay A, Mandalakas AM, Lange C. Whispers in the wind: Face mask sampling for Mycobacterium tuberculosis detection in children with pulmonary tuberculosis. J Infect Dis. 2024 May 27. PMID: 38798080.
      Citations: 1     Fields:    
    13. Gillespie SH, DiNardo AR, Georghiou SB, Sabiiti W, Kohli M, Panzner U, Kontsevaya I, Hittel N, Stuyver LJ, Tan JB, van Crevel R, Lange C, Thuong TNT, Heyckendorf J, Ruhwald M, Heinrich N. Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles. Lancet Microbe. 2024 Sep; 5(9):100869. PMID: 38735303.
      Citations:    Fields:    Translation:HumansCells
    14. Martinez L, Seddon JA, Horsburgh CR, Lange C, Mandalakas AM, TB Contact Studies Consortium. Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies. Lancet Respir Med. 2024 Aug; 12(8):633-641. PMID: 38734022.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    15. Brehm TT, Reimann M, K?hler N, Lange C. (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review. Clin Microbiol Infect. 2024 Aug; 30(8):989-998. PMID: 38663653.
      Citations: 1     Fields:    Translation:Humans
    16. Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR, Murray M, Lange C. Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024 Mar 24; 10(1):22. PMID: 38523140.
      Citations: 12     Fields:    Translation:Humans
    17. G?nther G, Guglielmetti L, Kherabi Y, Duarte R, Lange C, Tuberculosis Network European Trials group. Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe. Clin Microbiol Infect. 2024 Sep; 30(9):1197.e1-1197.e4. PMID: 38490355.
      Citations: 2     Fields:    Translation:HumansCells
    18. Kay A, Vasiliu A, Carratala-Castro L, Mtafya B, Mendez Reyes JE, Maphalala N, Munguambe S, Mulengwa D, Ness T, Saavedra B, Bacha J, Maphalala G, Mejia R, Mtetwa G, Acacio S, Manjate P, Mambuque E, Shiba N, Kota N, Ziyane M, Ntinginya NE, Lange C, Kirchner HL, DiNardo AR, Garcia-Basteiro AL, Mandalakas AM, Stool4TB Global Partnership, Mandalakas AM. Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study. Lancet Microbe. 2024 May; 5(5):e433-e441. PMID: 38461830; PMCID: PMC11142891.
      Citations: 2     Fields:    Translation:HumansCells
    19. Cristea V, K?dm?n C, Rosales-Klintz S, Zenner D, van der Werf M, Stoycheva K, Vasiliu A, Lange C. Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022. Euro Surveill. 2024 Mar; 29(12). PMID: 38516786; PMCID: PMC11063674.
      Citations:    Fields:    Translation:HumansPHPublic Health
    20. Carratala-Castro L, Ssengooba W, Kay A, Ac?cio S, Ehrlich J, DiNardo AR, Shiba N, Nsubuga JK, Munguambe S, Saavedra-Cervera B, Manjate P, Mulengwa D, Sibandze B, Ziyane M, Kasule G, Mambuque E, Sekadde MP, Wobudeya E, Joloba ML, Heyckendorf J, Lange C, Hermans S, Mandalakas A, Garc?a-Basteiro AL, Lopez-Varela E, Stool4TB Global Partnership. A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation. BMC Infect Dis. 2024 Feb 21; 24(1):233. PMID: 38383310; PMCID: PMC10880221.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    21. Nieuwenhuizen NE, Nouailles G, Sutherland JS, Zyla J, Pasternack AH, Heyckendorf J, Frye BC, H?hne K, Zedler U, Bandermann S, Abu Abed U, Brinkmann V, Gutbier B, Witzenrath M, Suttorp N, Zissel G, Lange C, Ritvos O, Kaufmann SHE, CAPNETZ Study group, DZIF TB study group. Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection. mBio. 2024 Mar 13; 15(3):e0340823. PMID: 38376260; PMCID: PMC10936190.
      Citations:    Fields:    Translation:HumansAnimalsCells
    22. Diacon AH, Barry CE, Carlton A, Chen RY, Davies M, de Jager V, Fletcher K, Koh GCKW, Kontsevaya I, Heyckendorf J, Lange C, Reimann M, Penman SL, Scott R, Maher-Edwards G, Tiberi S, Vlasakakis G, Upton CM, Aguirre DB. A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nat Med. 2024 Mar; 30(3):896-904. PMID: 38365949; PMCID: PMC10957473.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    23. Salzer HJF, Lange C. Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared with the reference standard-author's reply. Clin Microbiol Infect. 2024 May; 30(5):696-697. PMID: 38365116.
      Citations:    Fields:    Translation:HumansAnimals
    24. Carow B, Muliadi V, Sk?l?n K, Yokota C, Kathamuthu GR, Setiabudiawan TP, Lange C, Scheu K, Gaede KI, Goldmann T, Pandita A, Masood KI, Pervez S, Grunewald J, Hasan Z, Levin M, Rottenberg ME. Immune mapping of human tuberculosis and sarcoidosis lung granulomas. Front Immunol. 2023; 14:1332733. PMID: 38385142; PMCID: PMC10879604.
      Citations:    Fields:    Translation:HumansCells
    25. Neub?ck MJ, G?nther G, Barac A, Davidsen JR, Laursen CB, Agarwal R, Sehgal IS, Lange C, Salzer HJF, for CPAnet. Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease. Semin Respir Crit Care Med. 2024 Feb; 45(1):102-113. PMID: 38196060.
      Citations:    Fields:    Translation:Humans
    26. Otto-Knapp R, Bauer T, Brinkmann F, Feiterna-Sperling C, Friesen I, Geerdes-Fenge H, Hartmann P, H?cker B, Hauer B, Haas W, Heyckendorf J, Kuhns M, Lange C, Maurer FP, Nienhaus A, Priwitzer M, Richter E, Salzer HJF, Schoch O, Sch?nfeld N, Schaberg T. [Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]. Pneumologie. 2024 Jan; 78(1):35-46. PMID: 37931778.
      Citations:    Fields:    Translation:Humans
    27. Lange C, Vasiliu A, Mandalakas AM. Emerging bedaquiline-resistant tuberculosis. Lancet Microbe. 2023 12; 4(12):e964-e965. PMID: 37931639; PMCID: PMC11460056.
      Citations: 1     Fields:    Translation:Humans
    28. K?hler N, Vasiliu A, Mandalakas AM, Martinez L, Lange C, TBnet. Tuberculosis screening in migrants to the EU/EEA and UK. Eur Respir J. 2023 11; 62(5). PMID: 37918879.
      Citations:    Fields:    Translation:HumansPHPublic Health
    29. Gupta RK, Hamada Y, Bonnet M, Sester M, Vasiliu A, Martinez L, Ness T, Kay A, Kaufmann SHE, Lange C, Mandalakas AM. Tuberculosis prevention: current strategies and future directions. Clin Microbiol Infect. 2024 Sep; 30(9):1123-1130. PMID: 37918510; PMCID: PMC11524220.
      Citations: 1     Fields:    
    30. K?hler N, Karak?se H, Grobbel HP, Hillemann D, Andres S, K?nig C, Kalsdorf B, Brehm TT, B?ttcher L, Friesen I, Hoffmann H, Strelec D, Schaub D, Peloquin CA, Schmiedel S, Decosterd LA, Choong E, Wicha SG, Aarnoutse RE, Lange C, S?nchez Carballo PM. A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis. Pharmaceutics. 2023 Oct 27; 15(11). PMID: 38004523; PMCID: PMC10674734.
      Citations:    
    31. Kontsevaya I, Heyckendorf J, Koops F, Hillemann D, Goldmann T, Upton CM, De Jager V, Diacon A, Lange C. Transrenal Mycobacterium tuberculosis DNA in pulmonary tuberculosis patients during the first 14 days of treatment. Microbiol Spectr. 2023 Dec 12; 11(6):e0234823. PMID: 37882572; PMCID: PMC10714760.
      Citations:    Fields:    Translation:HumansCells
    32. Dreyer V, Utpatel C, Gr?schel MI, Ciobanu N, Crudu V, Heyckendorf J, Merker M, Chesov E, Chesov D, Reimann M, Lange C. Impact of Mycobacterium tuberculosis strain type on multidrug-resistant tuberculosis severity, Republic of Moldova. J Infect. 2023 12; 87(6):588-591. PMID: 37827458.
      Citations:    Fields:    Translation:HumansCells
    33. Saluzzo F, Adepoju VA, Duarte R, Lange C, Phillips PPJ. Treatment-shortening regimens for tuberculosis: updates and future priorities. Breathe (Sheff). 2023 Sep; 19(3):230028. PMID: 37830101; PMCID: PMC10567072.
      Citations: 2     
    34. Vasiliu A, Altpeter E, ?gisd?ttir TR, Amerali M, Bakos ?, D'Amato S, Cirillo DM, Davidaviciene E, Demuth I, Dom?nguez J, Guthmann JP, Hatzianastasiou S, Holm LH, Herrador Z, Hribar U, Huberty C, Ibraim E, Jackson S, Jensenius M, Josefsdottir KS, Korzeniewska-Kosela M, Kuksa L, Kunst H, Muylle I, Pace-Asciak A, Petrovic G, Pieridou D, Russo G, Rzhepishevska O, Marques MS, Schmid D, Sukholytka M, Svetina P, Tyufekchieva M, Viiklepp P, Villand K, Wallenfels J, Wesolowski S, Martinez L, TBnet, K?hler N, de O?ate WA, van Crevel R, Duarte R, G?nther G, Koch A, Lienhardt C, Mahler B, Makek MJ, Normark J, Salzer HJF, Solovic I, Vasankari T, Mandalakas AM, Zenner D, Lange C. Tuberculosis incidence in foreign-born people residing in European countries in 2020. Euro Surveill. 2023 10; 28(42). PMID: 37855907; PMCID: PMC10588305.
      Citations:    Fields:    Translation:Humans
    35. Davidsen JR, Laursen CB, Van Braeckel E, Agarwal R, Munteanu O, Irfan M, CPAnet, Salzer HJF, Reimann M, Oertel C, Avsar K, Lange C. Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard. Clin Microbiol Infect. 2023 Dec; 29(12):1605.e1-1605.e4. PMID: 37689265.
      Citations: 2     Fields:    Translation:HumansAnimals
    36. Lange C. Mission (im)possible: elimination of tuberculosis. Clin Microbiol Infect. 2024 Sep; 30(9):1105-1106. PMID: 37544609.
      Citations:    Fields:    
    37. Dheda K, G?nther G, Kherabi Y, McIlleron HM, Stagg HR, Guglielmetti L, Motta I, Boeree M, Chesov D, Horsburgh CR, Lange C, Lienhardt C, Paton NI, Thwaites G, Udwadia Z, Van Crevel R, Vel?squez GE, Wilkinson RJ, Study group on Mycobacteria (ESGMYC) of the European Society of Clinical Microbiology and Infectious. Recent advances in the treatment of tuberculosis. Clin Microbiol Infect. 2024 Sep; 30(9):1107-1114. PMID: 37482332.
      Citations: 5     Fields:    
    38. Ness T, Van LH, Petermane I, Duarte R, Lange C, Menzies D, Cirillo DM. Rolling out new anti-tuberculosis drugs without diagnostic capacity. Breathe (Sheff). 2023 Jun; 19(2):230084. PMID: 37492347; PMCID: PMC10365078.
      Citations: 1     
    39. Brehm TT, K?hler N, Schmiedel S, Terhalle E, Martensen J, Kalsdorf B, Kandulla J, Heyckendorf J, Kuhns M, Friesen I, Lange C. [Treatment of tuberculosis: what is new?] Inn Med (Heidelb). 2023 Jul; 64(7):701-707. PMID: 37316702.
      Citations:    Fields:    Translation:Humans
    40. Noroc E, Chesov D, Merker M, Gr?schel MI, Barilar I, Dreyer V, Ciobanu N, Reimann M, Crudu V, Lange C. Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova. Emerg Infect Dis. 2023 05; 29(5):1046-1050. PMID: 37081601; PMCID: PMC10124655.
      Citations:    Fields:    Translation:HumansCells
    41. Jafari C, Olaru ID, Daduna F, Lange C, Kalsdorf B. Rapid Diagnosis of Recurrent Paucibacillary Tuberculosis. Pathog Immun. 2022; 7(2):189-202. PMID: 37207169; PMCID: PMC10189871.
      Citations: 1     
    42. Villar-Hern?ndez R, Ghodousi A, Konstantynovska O, Duarte R, Lange C, Raviglione M. Tuberculosis: current challenges and beyond. Breathe (Sheff). 2023 Mar; 19(1):220166. PMID: 37334103; PMCID: PMC10270564.
      Citations:    
    43. Dom?nguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gr?schel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR, Lange C, TBnet and RESIST-TB networks. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. Lancet Infect Dis. 2023 04; 23(4):e122-e137. PMID: 36868253; PMCID: PMC11460057.
      Citations: 2     Fields:    Translation:HumansCells
    44. Andres S, Friesen I, Maier C, Chesov D, Schaub D, Kalsdorf B, Reimann M, Lange C. Long-term treatment outcomes in patients with multidrug-resistant tuberculosis. Clin Microbiol Infect. 2023 Jun; 29(6):751-757. PMID: 36842637.
      Citations:    Fields:    Translation:HumansCells
    45. Vasiliu A, Saktiawati AMI, Duarte R, Lange C, Cirillo DM. Implementing molecular tuberculosis diagnostic methods in limited-resource and high-burden countries. Breathe (Sheff). 2022 Dec; 18(4):220226. PMID: 36865933; PMCID: PMC9973455.
      Citations:    
    46. Koehler N, Andres S, Merker M, Dreyer V, John A, Kuhns M, Krieger D, Choong E, Verougstraete N, Zur Wiesch PA, Wicha SG, K?nig C, Kalsdorf B, Sanchez Carballo PM, Schaub D, Werngren J, Sch?n T, Peloquin CA, Sch?nfeld N, Verstraete AG, Decosterd LA, Aarnoutse R, Niemann S, Maurer FP, Lange C. Pretomanid-resistant tuberculosis. J Infect. 2023 05; 86(5):520-524. PMID: 36738862.
      Citations:    
    47. Lange C, K?hler N, G?nther G. Regimens for Drug-Resistant Tuberculosis. N Engl J Med. 2023 01 12; 388(2):190. PMID: 36630637.
      Citations: 1     Fields:    Translation:Humans
    48. Hamada Y, Gupta RK, Quartagno M, Izzard A, Acuna-Villaorduna C, Altet N, Diel R, Dominguez J, Floyd S, Gupta A, Huerga H, Jones-L?pez EC, Kinikar A, Lange C, van Leth F, Liu Q, Lu W, Lu P, Rueda IL, Martinez L, Mbandi SK, Mu?oz L, Padilla ES, Paradkar M, Scriba T, Sester M, Shanaube K, Sharma SK, Sloot R, Sotgiu G, Thiruvengadam K, Vashishtha R, Abubakar I, Rangaka MX. Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis. EClinicalMedicine. 2023 Feb; 56:101815. PMID: 36636295; PMCID: PMC9829704.
      Citations: 1     
    49. Tran F, Harris DMM, Scharmacher A, Gra?hoff H, Sterner K, Schinke S, K?ding N, Humrich JY, Cabral-Marques O, Bernardes JP, Mishra N, Bahmer T, Franzenburg J, Hoyer BF, Gl?ck A, Guggeis M, Ossysek A, K?ller A, Frank D, Lange C, Rupp J, Heyckendorf J, Gaede KI, Amital H, Rosenstiel P, Shoenfeld Y, Halpert G, Rosenberg AZ, Schulze-Forster K, Heidecke H, Riemekasten G, Schreiber S. Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19. ERJ Open Res. 2022 Oct; 8(4). PMID: 36575710; PMCID: PMC9571165.
      Citations: 2     
    50. Ness TE, Meiwes L, Kay A, Mejia R, Lange C, Farhat M, Mandalakas A, DiNardo A. Optimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications. Microbiol Spectr. 2023 02 14; 11(1):e0226922. PMID: 36475757; PMCID: PMC9927083.
      Citations: 1     Fields:    Translation:HumansCells
    51. Degenhardt F, Ellinghaus D, Juzenas S, Wendorff M, Uellendahl-Werth F, ElAbd H, Arora J, Lenning OB, Myhre R, Vadla MS, Wacker EM, Wienbrandt L, Garrido Chercoles A, Palom A, Garcia-Fernandez AE, Blanco-Grau A, Mantovani A, Zanella A, Holten AR, Bandera A, Cherubini A, Protti A, Aghemo A, Gerussi A, Ramirez A, Nebel A, Barreira A, Lleo A, Biondi A, Caballero-Garralda A, Ganna A, Gori A, Lind A, Tanck A, Hinney A, Carreras Nolla A, Fracanzani AL, Peschuck A, Cavallero A, Dyrhol-Riise AM, Ruello A, Muscatello A, Pesenti A, Voza A, Rando-Segura A, Schmidt A, Cortes B, Nafria-Jimenez B, Schaefer B, Bellinghausen C, Maj C, Scollo C, Herr C, Spinner CD, Gassner C, Hu C, Paccapelo C, Lehmann C, Angelini C, Cappadona C, COVICAT study group, Aachen Study (COVAS), Bianco C, Cea C, Sancho C, Hoff DAL, Galimberti D, Prati D, Haschka D, Toapanta D, Azzolini E, Sandoval E, Binatti E, Scarpini E, Urrechaga E, Paraboschi EM, Pontali E, Reverter E, Contro E, Arana-Arri E, Ceriotti F, Martinelli-Boneschi F, Peyvandi F, Blasi F, Malvestiti F, Medrano FJ, Hanses F, Hemmrich-Stanisak G, Bellani G, Grasselli G, Pezzoli G, Costantino G, Albano G, Cardamone G, Bellelli G, Citerio G, Foti G, Lamorte G, Baselli G, Kurihara H, Neb H, My I, Kurth I, Pink I, de Rojas I, Holter JC, Afset JE, Rybniker J, Dopazo J, Schneider J, Bergan J, Barretina J, Goikoetxea J, Fazaal J, Risnes K, Banasik K, Gaede KI, Tonby K, Heggelund L, Bettini LR, Sumoy L, Terranova L, Nkambule L, Knopp L, Gustad LT, Garbarino L, Santoro L, Ostadreza M, Intxausti M, Berger MM, Schaefer M, Niemi MEK, Carrabba M, Figuera Basso ME, Valsecchi MG, Vehreschild MJGT, Manunta M, Acosta-Herrera M, Baldini M, Cazzaniga M, Grimsrud MM, Cornberg M, Castoldi M, Cordioli M, Cecconi M, D'Amato M, Augustin M, Tomasi M, Dreher M, Seilmaier MJ, Joannidis M, Wittig M, Mazzocco M, Ciccarelli M, Bocciolone M, Miozzo M, Imaz Ayo N, Blay N, Chueca N, Montano N, Braun N, Ludwig N, Marx N, Norwegian SARS-CoV-2 Study group, Cornely OA, Witzke O, Palmieri O, Pa Study Group, Faverio P, Preatoni P, Bonfanti P, Omodei P, Tentorio P, Castro P, Hoffmann P, Rosenstiel P, Schommers P, Ferrer R, Bals R, Gualtierotti R, Carpani R, Badalamenti S, Ciesek S, May S, Bombace S, Marsal S, Pigazzini S, Klein S, Pelusi S, Wilfling S, Bosari S, Volland S, Raychaudhuri S, Schreiber S, Heilmann-Heimbach S, Aliberti S, Dudman S, Wesse T, Zheng T, STORM Study group, The Humanitas Task Force, The Humanitas Gavazzeni Task Force, Eggermann T, Illig T, Brenner T, Pumarola T, Feldt T, Folseraas T, Gonzalez Cejudo T, Rimoldi V, Monzani V, Keitel V, Kopfnagel V, Andrade V, Albrecht W, Peter W, Farre X, Yi X, Khodamoradi Y, Latiano A, Goerg S, Bacher P, Koehler P, Tran F, Zoller H, Ludwig KU, Invernizzi P, Duga S, Hov JR, Asselta R, de Cid R, Valenti L, Karlsen TH, Franke A, Lerga-Jaso J, Maya-Miles D, R?hlemann MC, ?zer O, Blandino Ortiz A, de Salazar A, Ruiz A, Mayer A, Braun A, Teles A, Kildal AB, Gl?ck A, Juli? A, Solier A, Mateos B, Jensen B, Ferrando C, de la Horra C, Quereda C, Skurk C, Thibeault C, Lange C, Azuure C, Jim?nez D, Pesta?a D, Mu?iz-Diaz E, Helbig ET, Casalone E, Calder?n EJ, Navas E, Sollig?rd E, Aziz F, Garcia F, Garc?a S?nchez F, Kurth F, Mesonero F, Rodriguez-Frias F, M?ller F, Matullo G, Hern?ndez I, Galv?n-Femenia I, Heyckendorf J, K?ssens J, Dam?s JK, Altm?ller J, Ampuero J, Mart?n J, Erdmann J, Banales JM, Badia JR, Walter J, Hern?ndez Quero J, Delgado J, Guerrero JM, Kraft J, Schr?der J, M?ller KE, Garcia-Etxebarria K, Izquierdo-Sanchez L, Sander LE, Lippert LJ, T?llez L, Roade L, Kogevinas M, Riveiro-Barciela M, Guti?rrez-Stampa MA, Hernandez-Tejero M, D'Angi? M, N?then MM, Marqui? M, Boada M, Rodr?guez-Gand?a M, Mart?nez N, Rodrigues PM, Espa?a PP, Suwalski P, de Pablo R, Gallego-Dur?n R, Nieto R, Morilla R, Haider S, Brunak S, Ripke S, Bahmer T, Landmesser U, Protzer U, Hehr U, Skogen V, Friaza V, Moreno V, Poller W, Wang X, Karadeniz Z, Schulte EC, Heidecker B, Fern?ndez J, Romero-G?mez M, et al. Detailed stratified GWAS analysis for severe COVID-19 in four European populations. Hum Mol Genet. 2022 11 28; 31(23):3945-3966. PMID: 35848942; PMCID: PMC9703941.
      Citations:    Fields:    
    52. Otto-Knapp R, H?cker B, Krieger D, Stete K, Starzacher K, Maier C, Heyckendorf J, Avsar K, Su?rez I, Rybniker J, Bauer T, G?nther G, Lange C. Long-term multidrug- and rifampicin-resistant tuberculosis treatment outcome by new WHO definitions in Germany. Eur Respir J. 2022 11; 60(5). PMID: 36423919.
      Citations:    Fields:    Translation:Humans
    53. Schaberg T, Brinkmann F, Feiterna-Sperling C, Geerdes-Fenge H, Hartmann P, H?cker B, Hauer B, Haas W, Heyckendorf J, Lange C, Maurer FP, Nienhaus A, Otto-Knapp R, Priwitzer M, Richter E, Salzer HJF, Schoch O, Sch?nfeld N, Stahlmann R, Bauer T. [Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients]. Pneumologie. 2022 Nov; 76(11):727-819. PMID: 36384164.
      Citations: 3     Fields:    Translation:Humans
    54. Dheda K, Lange C. A revolution in the management of multidrug-resistant tuberculosis. Lancet. 2022 11 26; 400(10366):1823-1825. PMID: 36368335.
      Citations: 1     Fields:    Translation:Humans
    55. Sibandze DB, Kay A, Dreyer V, Sikhondze W, Dlamini Q, DiNardo A, Mtetwa G, Lukhele B, Vambe D, Lange C, Dlamini MG, Ness T, Mejia R, Kalsdorf B, Heyckendorf J, Kuhns M, Maurer FP, Dlamini S, Maphalala G, Niemann S, Mandalakas A. Correction: Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 Sep 20; 14(1):107. PMID: 36127736; PMCID: PMC9487157.
      Citations:    
    56. DiNardo AR, Gandhi T, Heyckendorf J, Grimm SL, Rajapakshe K, Nishiguchi T, Reimann M, Kirchner HL, Kahari J, Dlamini Q, Lange C, Goldmann T, Marwitz S, DZIF-TB cohort study group, Cirillo JD, Kaufmann SHE, Netea MG, van Crevel R, Mandalakas AM, Coarfa C. Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes. Eur Respir J. 2022 09; 60(3). PMID: 35169026; PMCID: PMC9474892.
      Citations: 1     Fields:    
    57. Martinez L, Cords O, Liu Q, Acuna-Villaorduna C, Bonnet M, Fox GJ, Carvalho ACC, Chan PC, Croda J, Hill PC, Lopez-Varela E, Donkor S, Fielding K, Graham SM, Espinal MA, Kampmann B, Reingold A, Huerga H, Villalba JA, Grandjean L, Sotgiu G, Egere U, Singh S, Zhu L, Lienhardt C, Denholm JT, Seddon JA, Whalen CC, Garc?a-Basteiro AL, Triasih R, Chen C, Singh J, Huang LM, Sharma S, Hannoun D, Del Corral H, Mandalakas AM, Malone LL, Ling DL, Kritski A, Stein CM, Vashishtha R, Boulahbal F, Fang CT, Boom WH, Netto EM, Lemos AC, Hesseling AC, Kay A, Jones-L?pez EC, Horsburgh CR, Lange C, Andrews JR. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob Health. 2022 09; 10(9):e1307-e1316. PMID: 35961354; PMCID: PMC10406427.
      Citations:    
    58. Lange C, Wagner D. [Pulmonary Disease caused by less common Nontuberculous Mycobacteria - New international guidelines]. Dtsch Med Wochenschr. 2022 09; 147(17):1114-1121. PMID: 36030784.
      Citations:    
    59. G?nther G, Guglielmetti L, Leu C, Lange C, van Leth F, Tuberculosis Network European Trials group. Availability and costs of medicines for the treatment of tuberculosis in Europe. Clin Microbiol Infect. 2023 Jan; 29(1):77-84. PMID: 35961488; PMCID: PMC9801521.
      Citations:    
    60. Rachow A, Saathoff E, Mindru R, Popescu O, Lugoji D, Mahler B, Merker M, Niemann S, Olaru ID, Kastner S, Hoelscher M, Lange C, Ibraim E. Diagnostic performance of the AID line probe assay in the detection of Mycobacterium tuberculosis and drug resistance in Romanian patients with presumed TB. PLoS One. 2022; 17(8):e0271297. PMID: 35947609; PMCID: PMC9365181.
      Citations:    
    61. Donald P, Kaufmann S, Mandalakas AM, Lange C, Thee S. Pathogenesis of tuberculosis: the 1930 L?beck disaster revisited. Eur Respir Rev. 2022 Jun 30; 31(164). PMID: 35768133; PMCID: PMC9488810.
      Citations:    Fields:    Translation:HumansCells
    62. Van Braeckel E, Page I, Davidsen JR, Laursen CB, Agarwal R, Alastruey-Izquierdo A, Barac A, Cadranel J, Chakrabarti A, Cornely OA, Denning DW, Flick H, Gangneux JP, Godet C, Hayashi Y, Hennequin C, Hoenigl M, Irfan M, Izumikawa K, Koh WJ, Kosmidis C, Lange C, Lamprecht B, Laurent F, Munteanu O, Oladele R, Patterson TF, Watanabe A, Salzer HJF, CPAnet. Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement. Eur Respir J. 2022 06; 59(6). PMID: 35236726.
      Citations:    
    63. Sibandze DB, Kay A, Dreyer V, Sikhondze W, Dlamini Q, DiNardo A, Mtetwa G, Lukhele B, Vambe D, Lange C, Glenn Dlamini M, Ness T, Mejia R, Kuhns M, Dlamini S, Maphalala G, Niemann S, Mandalakas A, Kalsdorf B, Heyckendorf J, Maurer FP. Rapid molecular diagnostics of tuberculosis resistance by targeted stool sequencing. Genome Med. 2022 05 19; 14(1):52. PMID: 35585607; PMCID: PMC9118838.
      Citations: 1     Fields:    Translation:HumansCells
    64. Leu C, Cirillo D, Duarte R, Goletti D, Jankovic M, Kuksa L, Maurer FP, Tiberi S, van Leth F, Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), Tuberculosis Network European Trials group (TBnet), Guglielmetti L, G?nther G, Garcia-Basteiro AL, M?cha? F, Veziris N, Lange C. Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. Eur Respir J. 2022 05; 59(5). PMID: 35589114; PMCID: PMC9186306.
      Citations:    Fields:    Translation:Humans
    65. Lange C, Barry CE, Horsburgh CR. Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel. Am J Respir Crit Care Med. 2022 05 15; 205(10):1142-1144. PMID: 35320062; PMCID: PMC9872807.
      Citations:    Fields:    Translation:Humans
    66. Gutowski JP, Sachsenweger J, Lange C, May K, Heyckendorf J. [An Unexpected Complication: Contralateral Tension Pneumothorax following Transbronchial Forceps Biopsy]. Pneumologie. 2022 Sep; 76(9):622-625. PMID: 35405758.
      Citations:    Fields:    
    67. Chesov E, Chesov D, Maurer FP, Utpatel C, Barilar I, Donica A, Lange C, Crudu V, Andres S, Reimann M, Niemann S, Heyckendorf J, Merker M. Emergence of bedaquiline resistance in a high tuberculosis burden country. Eur Respir J. 2022 03; 59(3). PMID: 34503982; PMCID: PMC8943268.
      Citations: 2     Fields:    Translation:HumansCells
    68. Tunesi S, Gualano G, Millet JP, Skrahin A, Bothamley G, Casas X, Goletti D, Musso M, Palmieri F, Skrahina A, Viatushka D, TBnet, The ESGMYC, and The French MDR-TB Group, D? DL, Lange C, Pourcher V, Rioux C, Veziris N, Jachym-Fr?chet M, Guglielmetti L. Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study. J Infect. 2022 06; 84(6):834-872. PMID: 35271917.
      Citations: 1     Fields:    Translation:Humans
    69. Cambau E, Griffith DE, Guglielmetti L, van Ingen J, Knight SL, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, Wagner D, Winthrop K, Daley CL, expert panel group for management recommendations in non-tuberculous mycobacterial pulmonary disease, Lange C, B?ttger EC. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis. 2022 07; 22(7):e178-e190. PMID: 35090639.
      Citations: 1     Fields:    Translation:HumansCells
    70. Grobbel HP, Merker M, Hoffmann H, Heyckendorf J, Reimann M, Barilar I, Dreyer V, Hillemann D, Kalsdorf B, Kohl TA, Sanchez Carballo P, Schaub D, Todt K, Utpatel C, Maurer FP, Lange C, Niemann S, K?hler N, Andres S. Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing. Clin Infect Dis. 2021 10 05; 73(7):1194-1202. PMID: 33900387; PMCID: PMC8492214.
      Citations: 3     Fields:    Translation:HumansCells
    71. Roelens M, Battista Migliori G, Rozanova L, Estill J, Campbell JR, Cegielski JP, Tiberi S, Fox GJ, Sotgiu G, Brust JCM, Bang D, Lange C, Menzies D, Keiser O, Raviglione M, Palmero D, Guglielmetti L, Lienhardt C. Evidence-based Definition for Extensively Drug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2021 09 15; 204(6):713-722. PMID: 34107231.
      Citations: 3     Fields:    Translation:Humans
    72. Aaby P, Behr MA, Donald PR, Netea MG, Mandalakas AM, Lange C, Kaufmann SHE. 100 years of Mycobacterium bovis bacille Calmette-Gu?rin. Lancet Infect Dis. 2022 01; 22(1):e2-e12. PMID: 34506734.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    73. Heyckendorf J, Marwitz S, Reimann M, DiNardo AR, Hoelscher M, Ibraim E, Kalsdorf B, Kaufmann SHE, Kontsevaya I, van Leth F, Mandalakas AM, Maurer FP, Olaru ID, Popa C, Rachow A, Rolling T, Rybniker J, Salzer HJF, Sanchez-Carballo P, Schaub D, Spinu V, Terhalle E, Unnewehr M, Weiner J, Goldmann T, Lange C, Avsar K, G?nther G, M?ller M, Nitschkowski D, Schuhmann M, Su?rez I. Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. Eur Respir J. 2021 09; 58(3). PMID: 33574078.
      Citations: 3     Fields:    Translation:HumansCells
    74. Brandenburg J, Marwitz S, Tazoll SC, Vierbuchen T, Scholzen T, Gross A, Goldenbaum S, Hein M, Linnemann L, Reimann M, Kispert A, Leitges M, Behrends J, Goldmann T, Heine H, Reiling N, Waldow F, Kalsdorf B, H?lscher A, Rupp J, Lange C, Niemann S, Schaible UE, H?lscher C, Schwudke D. WNT6/ACC2-induced storage of triacylglycerols in macrophages is exploited by Mycobacterium tuberculosis. J Clin Invest. 2021 08 16; 131(16). PMID: 34255743; PMCID: PMC8363280.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    75. DZIF-TB cohort study group, Heyckendorf J, Reimann M, Marwitz S, Lange C. Pathogen-free diagnosis of tuberculosis. Lancet Infect Dis. 2021 08; 21(8):1066. PMID: 34331877.
      Citations:    Fields:    Translation:HumansCells
    76. Salzer HJF, Reimann M, Heldt S, Lange C, Hoelscher M, Rachow A, Massango I, Bhatt N, Machonisse E, Khosa C. Seroprevalence of Aspergillus-Specific IgG Antibody among Mozambican Tuberculosis Patients. J Fungi (Basel). 2021 Jul 23; 7(8). PMID: 34436134; PMCID: PMC8396907.
      Citations: 1     
    77. Chesov D, Heyckendorf J, Alexandru S, Donica A, Chesov E, Reimann M, Crudu V, Botnaru V, Lange C. Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country. Eur Respir J. 2021 06; 57(6). PMID: 33334942.
      Citations: 2     Fields:    Translation:Humans
    78. Kontsevaya I, Lange C, Coarfa C, DiNardo AR, Gillespie SH, Hauptmann M, Leschczyk C, Mandalakas AM, Martinecz A, Merker M, Niemann S, Reimann M, Schaible UE, Scheu KM, Abel Zur Wiesch P, Heyckendorf J, Comella-Del-Barrio P, Rzhepishevska O, Schurr E. Perspectives for systems biology in the management of tuberculosis. Eur Respir Rev. 2021 Jun 30; 30(160). PMID: 34039674; PMCID: PMC9488731.
      Citations: 1     Fields:    Translation:Humans
    79. Mandalakas AM, Hesseling AC, Kay A, Du Preez K, Martinez L, Ronge L, DiNardo A, Lange C, Kirchner HL. Tuberculosis prevention in children: a prospective community-based study in South Africa. Eur Respir J. 2021 04; 57(4). PMID: 33122339; PMCID: PMC8060782.
      Citations: 3     Fields:    Translation:Humans
    80. Lange C, Chesov D, Konstantynovska O, Mandalakas AM, Udwadia Z. Sorry for the delay. Clin Microbiol Infect. 2021 07; 27(7):941-943. PMID: 33823271; PMCID: PMC8079284.
      Citations:    Fields:    Translation:HumansCells
    81. Reimann M, Krabbe L, Gaede KI, Lange C, Herzmann C, J?nger C, R?ller S. Correction: Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis. PLoS One. 2021; 16(2):e0247693. PMID: 33606851; PMCID: PMC7894957.
      Citations:    Fields:    
    82. DiNardo AR, Nishiguchi T, Grimm SL, Schlesinger LS, Graviss EA, Cirillo JD, Coarfa C, Mandalakas AM, Heyckendorf J, Kaufmann SHE, Lange C, Netea MG, Van Crevel R. Tuberculosis endotypes to guide stratified host-directed therapy. Med. 2021 03 12; 2(3):217-232. PMID: 34693385; PMCID: PMC8530349.
      Citations: 3     Translation:HumansCells
    83. Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, Bordoni D, Geisen U, Josephs-Spaulding J, Rosati E, Aschenbrenner AC, Bacher P, Baran N, Boysen T, Bruse N, Elke G, Ellinghaus D, Fischer J, Forster M, Franke A, Frey N, Friedrichs A, Hamm J, Hinrichsen F, Hoeppner MP, Imm S, Kaiser S, Kan YH, Knoll R, Lange C, Laue G, Lindner M, Marinos G, Nattermann J, Noth R, Pickkers P, Rabe KF, Schaffarzyk A, Scheffold A, Schulte-Schrepping J, Schunk D, Skowasch D, Ulas T, Wittig M, Zimmermann J, Hoyer BF, Kaleta C, Heyckendorf J, Kox M, Rybniker J, Schreiber S, Schultze JL, Rosenstiel P, HCA Lung Biological Network, Deutsche COVID-19 Omics Initiative (DeCOI), Franzenburg J, K?hler P, K?nstner A, Brandt B, D?rr J, Dr?ger A, Franzenburg S, Fu? J, Gl?ck A, Junker R, Lier C, Markewitz R, Renz A, R?cken C, Rupp J, Wandinger KP, Busch H. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity. 2020 12 15; 53(6):1296-1314.e9. PMID: 33296687; PMCID: PMC7689306.
      Citations: 97     Fields:    Translation:HumansCells
    84. Kleinjohann L, Lange C. Respirators evaluated by fit testing. ERJ Open Res. 2020 Oct; 6(4). PMID: 33263063; PMCID: PMC7682718.
      Citations:    
    85. Kwak N, Winters N, Campbell JR, Chan ED, Gegia M, Lange C, Lee M, Milanov V, Menzies D, Yim JJ. Changes in treatment for multidrug-resistant tuberculosis according to national income. Eur Respir J. 2020 11; 56(5). PMID: 32586878.
      Citations:    
    86. Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, Altet N, Diel R, Dobler CC, Dominguez J, Doyle JS, Erkens C, Geis S, Haldar P, Hauri AM, Hermansen T, Johnston JC, Lange C, Lange B, van Leth F, Mu?oz L, Roder C, Romanowski K, Roth D, Sester M, Sloot R, Sotgiu G, Woltmann G, Yoshiyama T, Zellweger JP, Zenner D, Aldridge RW, Copas A, Rangaka MX, Lipman M, Noursadeghi M, Abubakar I. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med. 2020 12; 26(12):1941-1949. PMID: 33077958; PMCID: PMC7614810.
      Citations:    
    87. Lange C, Aarnoutse R, Chesov D, van Crevel R, Gillespie SH, Grobbel HP, Kalsdorf B, Kontsevaya I, van Laarhoven A, Nishiguchi T, Mandalakas A, Heyckendorf J, Reimann M, Ruhwald M, Sanchez-Carballo P, DiNardo AR, Merker M, Niemann S, K?hler N, Schwudke D, Waldow F. Perspective for Precision Medicine for Tuberculosis. Front Immunol. 2020; 11:566608. PMID: 33117351; PMCID: PMC7578248.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    88. Schildkraut JA, Gallagher J, Morimoto K, Lange C, Haworth C, Floto RA, Hoefsloot W, Griffith DE, Wagner D, Ingen JV, NTM-NET. Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation. Respir Med. 2020 11; 173:106164. PMID: 32992265.
      Citations: 5     Fields:    Translation:HumansCells
    89. Krabbe L, Gaede KI, Lange C, Herzmann C, J?nger C, Reimann M, R?ller S. Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis. PLoS One. 2020; 15(9):e0238619. PMID: 32956395; PMCID: PMC7505421.
      Citations: 2     Fields:    Translation:Humans
    90. Daley CL, Iaccarino JM, Lange C, Wallace RJ, Andrejak C, Brozek J, Griffith DE, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL, Cambau E, B?ttger EC, Guglielmetti L. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis. 2020 08 14; 71(4):905-913. PMID: 32797222; PMCID: PMC7768745.
      Citations: 55     Fields:    Translation:HumansCells
    91. Daley CL, Iaccarino JM, Lange C, Wallace RJ, Andrejak C, Brozek J, Griffith DE, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL, Cambau E, B?ttger EC, Guglielmetti L. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis. 2020 08 14; 71(4):e1-e36. PMID: 32628747; PMCID: PMC7768748.
      Citations: 93     Fields:    Translation:HumansCells
    92. Wagner D, Lange C. [Nontuberculous mycobacterial pulmonary disease - The new ATS/ERS/ESCMID/IDSA Guideline]. Dtsch Med Wochenschr. 2020 08; 145(16):1145-1151. PMID: 32791550.
      Citations:    Fields:    Translation:HumansCells
    93. Bisson GP, Bastos M, Campbell JR, Bang D, Brust JC, Isaakidis P, Lange C, Menzies D, Migliori GB, Pape JW, Palmero D, Baghaei P, Tabarsi P, Viiklepp P, Vilbrun S, Walsh J, Marks SM. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. Lancet. 2020 08 08; 396(10248):402-411. PMID: 32771107; PMCID: PMC8094110.
      Citations:    
    94. Luethgen M, Eggeling J, Heyckendorf J, Lange C, Maier C, Reimann M, Sassmann-Schweda A, Herzmann C, Shaikh R. Changes in taste and smell as an early marker for COVID-19. Int J Infect Dis. 2020 10; 99:8-9. PMID: 32707088; PMCID: PMC7373057.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    95. Udwadia ZF, Vora A, Tripathi AR, Malu KN, Lange C, Sara Raju R. COVID-19 -Tuberculosis interactions: When dark forces collide. Indian J Tuberc. 2020 Dec; 67(4S):S155-S162. PMID: 33308662; PMCID: PMC7362784.
      Citations: 15     Fields:    Translation:HumansCells
    96. Daley CL, Iaccarino JM, Lange C, Wallace RJ, Andrejak C, Brozek J, Griffith DE, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL, Cambau E, B?ttger EC, Guglielmetti L. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020 07; 56(1). PMID: 32636299; PMCID: PMC8375621.
      Citations: 62     Fields:    Translation:HumansCells
    97. Merker M, Heyckendorf J, Kalsdorf B, Rumetshofer R, Indra A, Hofmann-Thiel S, Hoffmann H, Lange C, Niemann S, Maurer FP, Andres S. Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon. Am J Respir Crit Care Med. 2020 06 15; 201(12):1564-1568. PMID: 32053752.
      Citations: 18     Fields:    Translation:HumansCells
    98. Abidi S, Achar J, Assao Neino MM, Bang D, Benedetti A, Brode S, Campbell JR, Casas EC, Conradie F, Dravniece G, du Cros P, Falzon D, Jaramillo E, Kuaban C, Lan Z, Lange C, Li PZ, Makhmudova M, Maug AKJ, Menzies D, Migliori GB, Miller A, Myrzaliev B, Ndjeka N, Noeske J, Parpieva N, Piubello A, Schwoebel V, Sikhondze W, Singla R, Souleymane MB, Tr?bucq A, Van Deun A, Viney K, Weyer K, Zhang BJ, Ahmad Khan F. Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis. Eur Respir J. 2020 03; 55(3). PMID: 31862767.
      Citations:    
    99. Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Kempker RR, Kipiani M, Kuksa L, Lange C, Nahid P, Rodrigues D, Singla R, Udwadia ZF, Menzies D, Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017, Guglielmetti L, Isaakidis P, Laniado-Labor?n R. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2020 04; 8(4):383-394. PMID: 32192585; PMCID: PMC7384398.
      Citations: 32     Fields:    Translation:HumansCells
    100. Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR, Lange C. Challenging the management of drug-resistant tuberculosis - Authors' reply. Lancet. 2020 03 07; 395(10226):783-784. PMID: 32145791.
      Citations:    Fields:    Translation:Humans
    101. Ezewudo M, Borens A, Chiner-Oms ?, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J. Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase. Sci Rep. 2020 Feb 21; 10(1):3531. PMID: 32081980; PMCID: PMC7035347.
      Citations:    
    102. Gruell H, Heyckendorf J, Lichtenstein T, Jung N, Lehmann C, Unnewehr M, Lange C, Rybniker J, Su?rez I, F?nger S, F?tkenheuer G. Intensified adjunctive corticosteroid therapy for CNS tuberculomas. Infection. 2020 Apr; 48(2):289-293. PMID: 31900872.
      Citations: 2     Fields:    Translation:Humans
    103. Lange C, Kalsdorf B, Maurer FP, Heyckendorf J. [Tuberculosis]. Internist (Berl). 2019 Nov; 60(11):1155-1175. PMID: 31641790.
      Citations: 1     Fields:    Translation:HumansCells
    104. Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR, Lange C. Management of drug-resistant tuberculosis. Lancet. 2019 09 14; 394(10202):953-966. PMID: 31526739; PMCID: PMC11524526.
      Citations: 39     Fields:    Translation:HumansCells
    105. Kranzer K, Kalsdorf B, Heyckendorf J, Merker M, Hofmann-Thiel S, Hoffmann H, Niemann S, Lange C, Maurer FP, Andres S, Bloemberg GV. New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared? Am J Respir Crit Care Med. 2019 08 15; 200(4):514-515. PMID: 31026398.
      Citations: 2     Fields:    Translation:Humans
    106. Tortoli E, Brown-Elliott BA, Chalmers JD, Cirillo DM, Daley CL, Emler S, Floto RA, Garcia MJ, Hoefsloot W, Koh WJ, Lange C, Loebinger M, Maurer FP, Morimoto K, Niemann S, Richter E, Turenne CY, Vasireddy R, Vasireddy S, Wagner D, Wallace RJ, Wengenack N, van Ingen J. Same meat, different gravy: ignore the new names of mycobacteria. Eur Respir J. 2019 Jul; 54(1). PMID: 31296783.
      Citations: 7     Fields:    Translation:HumansCells
    107. Kalsdorf B, Lange C. Tuberculous mediastinal lymphadenopathy: Reaching the target. Respirology. 2019 07; 24(7):622-623. PMID: 30897268.
      Citations:    Fields:    Translation:Humans
    108. van Leth F, Brinkmann F, Cirillo DM, Dheda K, Duarte R, Kuksa L, Lange C, Mitnick C, Skrahina A, Zaman K, Bothamley G, Guglielmetti L. The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation. Eur Respir J. 2019 01; 53(1). PMID: 30606765.
      Citations: 1     Fields:    Translation:Humans
    109. Sane Schepisi M, Navarra A, Dudnyk A, Dyrhol-Riise AM, Gualano G, Guglielmetti L, Heyckendorf J, Kaluzhenina A, Lange B, Lange C, Manika K, Miah J, Nanovic Z, Pontali E, Prego MR, Solovic I, Tiberi S, Palmieri F, Girardi E, Altet Gomez MN, Esteban J, Giorgetti PF. Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study. Open Forum Infect Dis. 2019 Jan; 6(1):ofy337. PMID: 30697572; PMCID: PMC6330516.
      Citations: 6     
    110. Chesov D, Furin J, Udwadia Z, Dheda K, Lange C. Revising the definition of extensively drug-resistant tuberculosis. Lancet Respir Med. 2018 12; 6(12):893-895. PMID: 30420247.
      Citations: 1     Fields:    Translation:Humans
    111. Ezewudo M, Borens A, Chiner-Oms ?, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J. Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase. Sci Rep. 2018 10 18; 8(1):15382. PMID: 30337678; PMCID: PMC6194142.
      Citations:    
    112. Gr?schel MI, Walker TM, van der Werf TS, Lange C, Niemann S, Merker M. Pathogen-based precision medicine for drug-resistant tuberculosis. PLoS Pathog. 2018 10; 14(10):e1007297. PMID: 30335850; PMCID: PMC6193714.
      Citations:    
    113. Salzer HJF, Reimann M, Heyckendorf J, Kalsdorf B, Lange C, Prattes J, Flick H, Obersteiner S, Gaede KI, Herzmann C, Johnson GL, Hoenigl M. Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis. Front Microbiol. 2018; 9:2223. PMID: 30333797; PMCID: PMC6176022.
      Citations: 5     
    114. Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Brode SK, Brust JCM, Cai Y, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Gegia M, Gler MT, Gu S, Holtz TH, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D, Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment?2017, Bonnet M, Caumes E, Dalcolmo MP, Fr?chet-Jachym M, Fregona G, Gayoso R, Guglielmetti L, Hughes J, Isaakidis P, Laniado-Labor?n R, Maciel EL, Mohr E, Robert J, Veziris N. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018 09 08; 392(10150):821-834. PMID: 30215381; PMCID: PMC6463280.
      Citations: 162     Fields:    Translation:Humans
    115. Tiberi S, Burman M, Kunst H, Wejse C, Togonidze T, Bothamley G, Lange C, TBnet, of the TBnet QTc survey, Guglielmetti L. QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study. Eur Respir J. 2018 08; 52(2). PMID: 29880656.
      Citations: 9     Fields:    Translation:Humans
    116. Salzer HJF, Stoney RJ, Angelo KM, Rolling T, Grobusch MP, Libman M, Duvignaud A, Schwartz E, Bottieau E, Jordan S, Lange C, Hamer DH, GeoSentinel Surveillance Network, L?pez-V?lez R, ?sgeirsson H, Crespillo-And?jar C, Gautret P. Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997-2017. J Travel Med. 2018 08 01; 25(1). PMID: 30085265; PMCID: PMC6628256.
      Citations: 6     Fields:    Translation:Humans
    117. van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Magis-Escurra C, Muylle I, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C, for TBNET, G?nther G, Polcov? V. Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries. Am J Respir Crit Care Med. 2018 08 01; 198(3):379-386. PMID: 29509468.
      Citations: 4     Fields:    Translation:Humans
    118. Heyckendorf J, Olaru ID, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M, K?ser CU, Andres S, Sch?n T, Stureg?rd E. Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis". Antimicrob Agents Chemother. 2018 08; 62(8). PMID: 30054377; PMCID: PMC6105783.
      Citations:    Fields:    Translation:Humans
    119. Radloff J, Heyckendorf J, van der Merwe L, Sanchez Carballo P, Reiling N, Richter E, Lange C, Kalsdorf B. Mycobacterium Growth Inhibition Assay of Human Alveolar Macrophages as a Correlate of Immune Protection Following Mycobacterium bovis Bacille Calmette-Gu?rin Vaccination. Front Immunol. 2018; 9:1708. PMID: 30087678; PMCID: PMC6066571.
      Citations: 2     Fields:    
    120. Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, Kosmidis C, Lange C, Munteanu O, Page I, Salzer HJF, on?behalf?of?CPAnet. Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives. Respiration. 2018; 96(2):159-170. PMID: 29982245.
      Citations:    
    121. Kuempers C, Pasternack H, Bialek R, Salzer HJF, Heyckendorf J, Palade E, Hundack L, Kalsdorf B, Lange C. An Unexpected Endobronchial Mass Appearing During Bronchoscopy. Chest. 2018 07; 154(1):e13-e21. PMID: 30044749.
      Citations:    Fields:    Translation:HumansAnimals
    122. Salzer HJF, Burchard G, Lange C, Rolling T, Schmiedel S, Capone D, Le T, Dalcolmo MP, Heyckendorf J, Cornely OA, Libman M. Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary Disease. Respiration. 2018; 96(3):283-301. PMID: 29953992.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    123. Jafari C, Olaru ID, Daduna F, Ernst M, Heyckendorf J, Lange C, Kalsdorf B. Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods. Eur Respir J. 2018 05; 51(5). PMID: 29599184.
      Citations: 5     Fields:    Translation:HumansCells
    124. Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment. Respirology. 2018 Jul; 23(7):656-673. PMID: 29641838.
      Citations: 50     Fields:    Translation:HumansCells
    125. Salzer HJF, Hoenigl M, Hoffmann C, Kalsdorf B, Lange C, Sch?fer G, G?nther G, Alanio A. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia. Respiration. 2018; 96(1):52-65. PMID: 29635251.
      Citations: 50     Fields:    Translation:HumansAnimals
    126. Dheda K, Gumbo T, Horsburgh CR, Furin J, Lange C. Pan-tuberculosis regimens: an argument against. Lancet Respir Med. 2018 04; 6(4):240-242. PMID: 29595502.
      Citations: 6     Fields:    Translation:HumansCells
    127. Lange C, van Leth F, Mitnick CD, Dheda K, G?nther G. Time to revise WHO-recommended definitions of MDR-TB treatment outcomes. Lancet Respir Med. 2018 04; 6(4):246-248. PMID: 29595505.
      Citations:    
    128. van Ingen J, Aksamit T, Andrejak C, Daley CL, Griffith DE, Holland SM, Huitt GA, Koh WJ, Lange C, Leitman P, Marras TK, Morimoto K, Olivier KN, Santin M, Stout JE, Thomson R, Tortoli E, Wallace RJ, Winthrop KL, Wagner D, for NTM-NET, B?ttger EC, Cambau E, Guglielmetti L. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J. 2018 03; 51(3). PMID: 29567726; PMCID: PMC6660914.
      Citations: 53     Fields:    Translation:HumansCells
    129. Heyckendorf J, van Leth F, Kalsdorf B, Olaru ID, Salzer HJF, Terhalle E, Rolling T, Glattki G, Schuhmann M, Lange C, G?nther G, M?ller M, Avsar K. Relapse-free cure from multidrug-resistant tuberculosis in Germany. Eur Respir J. 2018 02; 51(2). PMID: 29467205.
      Citations: 1     Fields:    Translation:Humans
    130. Olaru ID, Van Den Broucke S, Rosser AJ, Salzer HJF, Woltmann G, Bottieau E, Lange C. Pulmonary Diseases in Refugees and Migrants in Europe. Respiration. 2018; 95(4):273-286. PMID: 29414830.
      Citations:    
    131. Dudnyk A, Chesov D, Lange C. Mission impossible: the End TB strategy. Int J Tuberc Lung Dis. 2018 02 01; 22(2):121-122. PMID: 29506606.
      Citations: 2     Fields:    Translation:Humans
    132. Heyckendorf J, Olaru ID, Schleusener V, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Lange C, Andres S, K?ser CU, Sch?n T, Stureg?rd E, Beckert P, Kohl TA, Niemann S, Merker M. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2018 02; 62(2). PMID: 29133554; PMCID: PMC5786814.
      Citations: 33     Fields:    Translation:HumansCells
    133. Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, K?ser CU, Rodwell TC. A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis. Eur Respir J. 2017 12; 50(6). PMID: 29284687; PMCID: PMC5898944.
      Citations:    
    134. van Leth F, G?nther G, Hoffmann H, Lange C, European MDR-TB Database Collaboration. Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria. Am J Respir Crit Care Med. 2017 12 01; 196(11):1489-1490. PMID: 28715229.
      Citations:    
    135. De Pascale G, Ranzani OT, Nseir S, Chastre J, Welte T, Antonelli M, Navalesi P, Garofalo E, Bruni A, Coelho LM, Skoczynski S, Longhini F, Taccone FS, Grimaldi D, Salzer HJF, Lange C, Froes F, Artigas A, D?az E, Vall?s J, Rodr?guez A, Panigada M, Comellini V, Fasano L, Soave PM, Spinazzola G, Luyt CE, Alvarez-Lerma F, Marin J, Masclans JR, Chiumello D, Pezzi A, Schultz M, Mohamed H, Van Der Eerden M, Hoek RAS, Gommers DAMPJ, Pasquale MD, Civljak R, Kutle?a M, Bassetti M, Dimopoulos G, Nava S, Rios F, Zampieri FG, Povoa P, Bos LD, Aliberti S, Torres A, Mart?n-Loeches I. Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project. ERJ Open Res. 2017 Oct; 3(4). PMID: 29164144; PMCID: PMC5691166.
      Citations:    
    136. Herzmann C, Ernst M, Lange C, Stenger S, Kaufmann SHE, Reiling N, Schaberg T, van der Merwe L, Maertzdorf J, Tb or not Tb consortium. Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals. PLoS One. 2017; 12(11):e0187882. PMID: 29125874; PMCID: PMC5695274.
      Citations: 3     Fields:    Translation:HumansCells
    137. Dedicoat MJ, G?nther G, Crudu V, Duarte R, Gualano G, Magis-Escurra C, Rumetshofer R, Skrahina A, Spinu V, Tiberi S, Viiklepp P, van Leth F, Lange C, for TBNET ?. Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure. Am J Respir Crit Care Med. 2017 11 01; 196(9):1222-1224. PMID: 28323453.
      Citations:    
    138. Chesov D, Ciobanu N, Lange C, Heyckendorf J, Crudu V. High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova. Eur Respir J. 2017 10; 50(4). PMID: 29025881.
      Citations: 2     Fields:    Translation:HumansCells
    139. Chesov D, Ciobanu N, Lange C, Heyckendorf J, Crudu V, Sch?n T. Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the katG 315T mutation. Eur Respir J. 2017 10; 50(4). PMID: 29025884.
      Citations: 1     Fields:    Translation:HumansCells
    140. Bothamley GH, Lange C, TBNET. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study. Respir Med. 2017 Nov; 132:68-75. PMID: 29229108.
      Citations:    
    141. Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, Lange C. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology. 2018 01; 23(1):36-45. PMID: 28850767.
      Citations:    
    142. Salzer HJF, Heyckendorf J, Kalsdorf B, Herzmann C, Hoffmann C, Lange C. Chronic Cough and Severe Weight Loss in a 55-Year-Old Previously Healthy Man. Clin Infect Dis. 2017 07 15; 65(2):349-351. PMID: 28931270.
      Citations: 2     Fields:    
    143. Heyckendorf J, Lange C, Priwitzer M, Richter E, Schaberg T, Bauer T, Brinkmann F, Diel R, Feiterna-Sperling C, Haas W, Hartmann P, Hauer B, Nienhaus A, Otto-Knapp R, Rumetshofer R, Schenkel K, Schoch OD, Sch?nfeld N, Stahlmann R. [Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)]. Pneumologie. 2017 Jun; 71(6):325-397. PMID: 28651293.
      Citations: 22     Fields:    Translation:Humans
    144. Magis-Escurra C, G?nther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcov? V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F, for TBnet. Treatment outcomes of MDR-TB and HIV co-infection in Europe. Eur Respir J. 2017 06; 49(6). PMID: 28596434.
      Citations:    
    145. Olaru ID, Heyckendorf J, Kalsdorf B, Lange C, Andres S. Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis. Eur Respir J. 2017 05; 49(5). PMID: 28529207.
      Citations: 9     Fields:    Translation:Humans
    146. Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Nahid P, Udwadia ZF, Horsburgh CR, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Padayatchi N, Warren RM, Lange C, Jara CM. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017 Mar 15. PMID: 28344011.
      Citations: 168     Fields:    
    147. van Ingen J, Wagner D, Gallagher J, Morimoto K, Lange C, Haworth CS, Floto RA, Adjemian J, Prevots DR, Griffith DE, NTM-NET. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. Eur Respir J. 2017 02; 49(2). PMID: 28182571.
      Citations: 29     Fields:    Translation:HumansCells
    148. Dudnyk A, Butov D, Crudu V, Chesov D, Lange C. MDR-TB in Eastern Europe in the era of the TB elimination action framework. Int J Tuberc Lung Dis. 2017 01 01; 21(1):2-3. PMID: 28157456.
      Citations:    Fields:    Translation:Humans
    149. Lange C, G?nther G, van Leth F, TBNET. More on Treatment Outcomes in Multidrug-Resistant Tuberculosis. N Engl J Med. 2016 12 29; 375(26):2611. PMID: 28029919.
      Citations:    
    150. Salzer HJ, Heyckendorf J, Kalsdorf B, Rolling T, Lange C. Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID/ERS/ECMM and IDSA guidelines. Mycoses. 2017 Feb; 60(2):136-142. PMID: 27910139.
      Citations: 11     Fields:    Translation:HumansAnimals
    151. Herzmann C, Sotgiu G, Diel R, Gerdes S, Goetsch U, Heykes-Uden H, Schaberg T, Lange C, TB or not TB consortium, Bellinger O. Risk for latent and active tuberculosis in Germany. Infection. 2017 Jun; 45(3):283-290. PMID: 27866367; PMCID: PMC5488071.
      Citations: 12     Fields:    Translation:Humans
    152. Labugger I, Heyckendorf J, Dees S, Herzmann C, Kohl TA, Richter E, Rivera-Milla E, Lange C, H?ussinger E. Detection of transrenal DNA for the diagnosis of pulmonary tuberculosis and treatment monitoring. Infection. 2017 Jun; 45(3):269-276. PMID: 27798774.
      Citations: 13     Fields:    Translation:HumansCells
    153. Heyckendorf J, Labugger I, van der Merwe L, Diacon AH, Garcia-Basteiro AL, Lange C. Serial measurements of transrenal mycobacterial DNA as indicators of the early bactericidal activity (EBA) of antituberculosis drugs. Tuberculosis (Edinb). 2017 01; 102:31-33. PMID: 28061950.
      Citations: 1     Fields:    Translation:HumansCells
    154. Lange C, Duarte R, Guenther G, Guglielmetti L, Olaru ID, Oliveira O, Rumetshofer R, van Leth F, European MDR-TB database collaboration *, Fr?chet-Jachym M, Veziris N. Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe. Am J Respir Crit Care Med. 2016 10 15; 194(8):1029-1031. PMID: 27685538.
      Citations: 15     Fields:    Translation:Humans
    155. Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F, for TBNET, G?nther G, Polcov? V. Treatment Outcomes in Multidrug-Resistant Tuberculosis. N Engl J Med. 2016 Sep 15; 375(11):1103-5. PMID: 27626539.
      Citations: 18     Fields:    Translation:HumansCells
    156. Lange C, Siddiqui S. State-of-the-Art Series on Precision Medicine in Respiratory Diseases. Respiration. 2016; 92(4):197-198. PMID: 27626791.
      Citations:    Fields:    Translation:Humans
    157. Salzer HJ, Wassilew N, Olaru ID, Herzmann C, Kalsdorf B, Sanchez-Carballo P, Terhalle E, Rolling T, Lange C, Heyckendorf J, K?hler N, G?nther G. Personalized Medicine for Chronic Respiratory Infectious Diseases: Tuberculosis, Nontuberculous Mycobacterial Pulmonary Diseases, and Chronic Pulmonary Aspergillosis. Respiration. 2016; 92(4):199-214. PMID: 27595540.
      Citations: 4     Fields:    Translation:HumansCells
    158. Olaru ID, Lange C, Indra A, Meidlinger L, Huhulescu S, Rumetshofer R. High Rates of Treatment Success in Pulmonary Multidrug-Resistant Tuberculosis by Individually Tailored Treatment Regimens. Ann Am Thorac Soc. 2016 08; 13(8):1271-8. PMID: 27163360.
      Citations: 4     Fields:    Translation:Humans
    159. Salzer HJF, Terhalle E, Lange C. Extensively drug-resistant tuberculosis in long-term travellers. Lancet Infect Dis. 2016 06; 16(6):642-643. PMID: 27301923.
      Citations:    Fields:    Translation:HumansCells
    160. Mitnick CD, Rodriguez CA, Hatton ML, Cobelens F, Grobusch MP, Horsburgh R, Lange C, Lienhardt C, Oren E, Podewils LJ, Seaworth B, van den Hof S, Daley CL, Gebhard AC, Wares F, RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative), Brigden G. Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda. PLoS One. 2016; 11(5):e0155968. PMID: 27223622; PMCID: PMC4880345.
      Citations: 9     Fields:    Translation:Humans
    161. Wassilew N, Hoffmann H, Andrejak C, Lange C. Pulmonary Disease Caused by Non-Tuberculous Mycobacteria. Respiration. 2016; 91(5):386-402. PMID: 27207809.
      Citations: 40     Fields:    Translation:HumansCells
    162. Merker M, Crudu V, Noroc E, Romancenco E, Chesov D, Niemann S, Lange C, G?nther G. In reply. Int J Tuberc Lung Dis. 2016 Mar; 20(3):424. PMID: 27046728.
      Citations:    Fields:    
    163. DiNardo AR, Lange C, Mandalakas AM. Editorial Commentary: 1, 2, 3 (Years)?????and You're Out: The End of a 123-year Historic Era. Clin Infect Dis. 2016 May 01; 62(9):1089-91. PMID: 26839384.
      Citations: 1     Fields:    Translation:HumansCells
    164. van Leth F, Sester M, TBnet, Lange C. Viral Load and Risk of Tuberculosis in HIV Infection. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):e51-3. PMID: 26761521.
      Citations: 2     Translation:HumansCells
    165. Mandalakas AM, Denkinger CM, Sester M, Lange C, Kalsdorf B. Clinical Application of Interferon-? Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence. Pathog Immun. 2016; 1(2):308-329. PMID: 28217762; PMCID: PMC5315027.
      Citations: 6     
    166. Salzer HJ, Rolling T, Schmiedel S, Klupp EM, Lange C, Seifert H. Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects Drugs. Emerg Infect Dis. 2016 Jan; 22(1):134-7. PMID: 26689082; PMCID: PMC4696709.
      Citations:    
    167. Sester M, van Crevel R, Leth Fv, Lange C. Numbers needed to treat to prevent tuberculosis. Eur Respir J. 2015 Dec; 46(6):1836-8. PMID: 26621887.
      Citations: 10     Fields:    Translation:HumansCells
    168. Olaru ID, Lange C, Heyckendorf J. Personalized medicine for patients with MDR-TB. J Antimicrob Chemother. 2016 Apr; 71(4):852-5. PMID: 26507429.
      Citations: 10     Fields:    Translation:HumansCells
    169. Parida SK, Poiret T, Zhenjiang L, Meng Q, Heyckendorf J, Ambati AS, Rao MV, Valentini D, Ferrara G, Rangelova E, Dodoo E, Zumla A, Maeurer M, Lange C. T-Cell Therapy: Options for Infectious Diseases. Clin Infect Dis. 2015 Oct 15; 61Suppl 3:S217-24. PMID: 26409284; PMCID: PMC4583575.
      Citations: 18     Fields:    Translation:HumansCells
    170. Olaru ID, Lange C, Sester M. Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis. Am J Respir Crit Care Med. 2015 Oct 15; 192(8):1021-2. PMID: 26469848.
      Citations:    
    171. Kalsdorf B, Olaru ID, Lange C, Heyckendorf J. [Tuberculosis]. Dtsch Med Wochenschr. 2015 Oct; 140(20):1508-12. PMID: 26445253.
      Citations:    Fields:    Translation:Humans
    172. Heyckendorf J, Aries SP, Greinert U, Richter E, Schultz H, Lange C. Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection. Emerg Infect Dis. 2015 Sep; 21(9):1685-7. PMID: 26291675; PMCID: PMC4550166.
      Citations: 2     Fields:    Translation:HumansCells
    173. Blauenfeldt T, Wagner D, Aabye M, Heyckendorf J, Lange B, Ernst M, Duarte R, Morais C, Hoffmann M, Schoch OD, Ruhwald M, Lange C, Ravn P, Dominguez J, Latorre I. Thermostability of IFN-? and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study. Tuberculosis (Edinb). 2016 05; 98:7-12. PMID: 27156612.
      Citations: 3     Fields:    Translation:HumansCells
    174. Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fresard I, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Rath H, Ringshausen FC, Solovic I, Widmer U, Witte P, Lange C, TBNET, Fl?e A, Garc?a-Garc?a JM, Pache G, Ruiz AS, Souza-Galv?o ML. Risk Assessment of Tuberculosis in Contacts by IFN-? Release Assays. A Tuberculosis Network European Trials Group Study. Am J Respir Crit Care Med. 2015 May 15; 191(10):1176-84. PMID: 25763458.
      Citations: 37     Fields:    Translation:HumansCellsPHPublic Health
    175. Dudnyk A, Rzhepishevska O, Rogach K, Kutsyna G, Lange C. Multidrug-resistant tuberculosis in Ukraine at a time of military conflict. Int J Tuberc Lung Dis. 2015 Apr; 19(4):492-3. PMID: 25860008.
      Citations:    
    176. Chesov D, Daduna F, Crudu V, Ernst M, Kalsdorf B, Lange C, Preyer R. Combined antigen-specific interferon-? and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection. PLoS One. 2015; 10(3):e0120006. PMID: 25785445; PMCID: PMC4364905.
      Citations: 3     Fields:    Translation:HumansCells
    177. G?nther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcov? V, Pontali E, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C, TBNET. Multidrug-resistant tuberculosis in Europe, 2010-2011. Emerg Infect Dis. 2015 Mar; 21(3):409-16. PMID: 25693485; PMCID: PMC4344280.
      Citations:    
    178. Herzmann C, Sotgiu G, Schaberg T, Ernst M, Stenger S, TB or not TB Consortium, Lange C. Childhood BCG vaccination does not influence control of Mycobacterium tuberculosis growth by human bronchoalveolar lavage cells. Tuberculosis (Edinb). 2015 May; 95(3):321-7. PMID: 25794470.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    179. Olaru ID, von Groote-Bidlingmaier F, Heyckendorf J, Yew WW, Chang KC, Lange C. Novel drugs against tuberculosis: a clinician's perspective. Eur Respir J. 2015 Apr; 45(4):1119-31. PMID: 25431273.
      Citations: 18     Fields:    Translation:Humans
    180. Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C, TBNET, Dom?nguez J. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med. 2014 Nov 15; 190(10):1168-76. PMID: 25303140.
      Citations: 68     Fields:    Translation:Humans
    181. Gomez GB, Lange C, Rupert S, van Leth F, TBNET, G?nther G. Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey. Eur Respir J. 2015 Apr; 45(4):1081-8. PMID: 25395035.
      Citations: 12     Fields:    Translation:Humans
    182. Gutsfeld C, Olaru ID, Vollrath O, Lange C. Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany. PLoS One. 2014; 9(11):e112681. PMID: 25393241; PMCID: PMC4231044.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    183. Lange C, Kampmann B. Preventive chemotherapy for contacts of MDR-TB: is the proof in the pudding? Int J Tuberc Lung Dis. 2014 Nov; 18(11):1262-3. PMID: 25299855.
      Citations:    Fields:    Translation:Humans
    184. de Visser V, Sotgiu G, Lange C, Aabye MG, Bakker M, Bartalesi F, Brat K, Chee CB, Dheda K, Eyuboglu F, Ghanem M, Goletti D, Dilektasli AG, Koh WJ, Losi M, Ringshausen FC, Rumetshofer R, Thijsen S, Bothamley G, Bossink A, TBNET, Dominguez J, Guglielmetti L, Latorre I, Polanova M, Ravn P, de Souza-Galv?o ML. False-negative interferon-? release assay results in active tuberculosis: a TBNET study. Eur Respir J. 2015 Jan; 45(1):279-83. PMID: 25359336.
      Citations: 13     Fields:    Translation:Humans
    185. Blauenfeldt T, Heyckendorf J, Graff Jensen S, Lange C, Drabe C, Hermansen TS, de Thurah L, Lillebaek T, Eugen-Olsen J, Seersholm N, Bonde J, Ruhwald M, Hoff S. Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots. PLoS One. 2014; 9(9):e105628. PMID: 25184553; PMCID: PMC4153573.
      Citations: 5     Fields:    Translation:HumansCells
    186. Hooli BV, Parrado AR, Mullin K, Yip WK, Liu T, Roehr JT, Qiao D, Jessen F, Peters O, Becker T, Ramirez A, Lange C, Bertram L, Tanzi RE. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk. Neurology. 2014 Oct 07; 83(15):1353-8. PMID: 25186855; PMCID: PMC4189101.
      Citations: 19     Fields:    Translation:Humans
    187. Olaru ID, Heyckendorf J, Grossmann S, Lange C. Time to culture positivity and sputum smear microscopy during tuberculosis therapy. PLoS One. 2014; 9(8):e106075. PMID: 25171337; PMCID: PMC4149502.
      Citations: 16     Fields:    Translation:HumansCells
    188. Essone PN, Kalsdorf B, Chegou NN, Kriel M, Preyer R, Ernst M, Walzl G, Lange C, Loxton AG. Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring. Respiration. 2014; 88(3):251-61. PMID: 25171202.
      Citations: 8     Fields:    Translation:HumansCells
    189. Heyckendorf J, Olaru ID, Ruhwald M, Lange C. Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis. Am J Respir Crit Care Med. 2014 Aug 15; 190(4):374-83. PMID: 24941306.
      Citations: 10     Fields:    Translation:HumansCells
    190. Choi S, Lee S, Cichon S, Lange C, Park T, Won S, N?then MM. FARVAT: a family-based rare variant association test. Bioinformatics. 2014 Nov 15; 30(22):3197-205. PMID: 25075118.
      Citations: 18     Fields:    Translation:Humans
    191. Herzmann C, Sotgiu G, Schaberg T, Ernst M, Stenger S, Lange C, German TB or Not TB Consortium. Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults. Eur Respir J. 2014 Oct; 44(4):1087-90. PMID: 24969658.
      Citations: 2     Fields:    Translation:HumansCells
    192. Yew WW, Lange C. Linezolid in the treatment of drug-resistant tuberculosis: the way forward? Int J Tuberc Lung Dis. 2014 Jun; 18(6):631-2. PMID: 24903928.
      Citations:    
    193. Kaufmann SH, Lange C, Rao M, Balaji KN, Lotze M, Schito M, Zumla AI, Maeurer M. Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. Lancet Respir Med. 2014 Apr; 2(4):301-20. PMID: 24717627.
      Citations: 83     Fields:    Translation:HumansCells
    194. Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM, TBNET, G?nther G, R?sch-Gerdes S. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014 Jul; 44(1):23-63. PMID: 24659544; PMCID: PMC4076529.
      Citations: 89     Fields:    Translation:HumansPHPublic Health
    195. Munteanu O, Chesov D, Rusu D, Lange C, Botnaru V. Pulmonary erythema migrans? Respiration. 2014; 87(3):252-3. PMID: 24434839.
      Citations:    Fields:    Translation:Humans
    196. Chegou NN, Heyckendorf J, Walzl G, Lange C, Ruhwald M. Beyond the IFN-? horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur Respir J. 2014 May; 43(5):1472-86. PMID: 24311770.
      Citations: 54     Fields:    Translation:HumansCells
    197. Qiao D, Cho MH, Fier H, Bakke PS, Gulsvik A, Silverman EK, Lange C. On the simultaneous association analysis of large genomic regions: a massive multi-locus association test. Bioinformatics. 2014 Jan 15; 30(2):157-64. PMID: 24262215; PMCID: PMC3892690.
      Citations: 2     Fields:    Translation:HumansCells
    198. Leung CC, Lange C, Zhang Y. Tuberculosis: current state of knowledge: an epilogue. Respirology. 2013 Oct; 18(7):1047-55. PMID: 23837600.
      Citations:    
    199. Won S, Lange C. A general framework for robust and efficient association analysis in family-based designs: quantitative and dichotomous phenotypes. Stat Med. 2013 Nov 10; 32(25):4482-98. PMID: 23740776.
      Citations: 7     Fields:    Translation:Humans
    200. Chee CB, Sester M, Zhang W, Lange C. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis. Respirology. 2013 Feb; 18(2):205-16. PMID: 23107218.
      Citations: 15     Fields:    Translation:HumansCells
    201. Kalsdorf B, Skolimowska KH, Scriba TJ, Dawson R, Dheda K, Wood K, Hofmeister J, Hanekom WA, Lange C, Wilkinson RJ. Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis. Eur J Immunol. 2013 Feb; 43(2):540-9. PMID: 23147374; PMCID: PMC3791514.
      Citations:    
    202. Lange C, Sester M. TB or not TB: the role of immunodiagnosis. Eur J Immunol. 2012 Nov; 42(11):2840-3. PMID: 23108933.
      Citations:    Fields:    Translation:HumansCells
    203. Sotgiu G, D'Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB. Availability of anti-tuberculosis drugs in Europe. Eur Respir J. 2012 Aug; 40(2):500-3. PMID: 22855471.
      Citations:    
    204. Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, Jones CE, Kampmann B, Kotton CN, Lange C, Ljungman P, Milburn H, Morris MI, Muller E, Nellore A, Rieder HL, Sester U, Theodoropoulos N, Wagner D, Sester M, Mu?oz P. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012 Oct; 40(4):990-1013. PMID: 22496318.
      Citations: 49     Fields:    Translation:HumansCells
    205. Herzmann C, Ernst M, Ehlers S, Stenger S, Maertzdorf J, Sotgiu G, Lange C. Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection. Eur Respir J. 2012 Dec; 40(6):1450-7. PMID: 22441737.
      Citations: 7     Fields:    Translation:HumansCells
    206. Andresen E, G?nther G, Bullwinkel J, Lange C, Heine H. Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One. 2011; 6(7):e21898. PMID: 21818276; PMCID: PMC3139569.
      Citations:    
    207. Andresen E, Lange C, Strodthoff D, Goldmann T, Fischer N, Sahly H, Branscheid D, Heine H. S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection. BMC Pulm Med. 2011 Feb 15; 11:10. PMID: 21324122; PMCID: PMC3050873.
      Citations: 7     Fields:    Translation:HumansCells
    208. Amos CI, Lange C. Family-based designs. IARC Sci Publ. 2011; (163):261-80. PMID: 22997867.
      Citations:    Fields:    Translation:Humans
    209. Krummel B, Strassburg A, Ernst M, Reiling N, Eker B, Rath H, Hoerster R, Wappler W, Glaewe A, Schoellhorn V, Sotgiu G, Lange C. Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing. PLoS One. 2010 Jul 20; 5(7):e11670. PMID: 20652022; PMCID: PMC2907387.
      Citations: 9     Fields:    Translation:HumansCells
    210. Herzmann C, G?nther G, Eker B, Lange C, Migliori GB. What about existing databases? Dtsch Arztebl Int. 2010 Jun; 107(24):435-6; author reply 436. PMID: 20607088; PMCID: PMC2897003.
      Citations:    
    211. Moerkerke B, Vansteelandt S, Lange C. A doubly robust test for gene-environment interaction in family-based studies of affected offspring. Biostatistics. 2010 Apr; 11(2):213-25. PMID: 20154305; PMCID: PMC2830581.
      Citations: 9     Fields:    Translation:Humans
    212. Lange C, Mori T. Advances in the diagnosis of tuberculosis. Respirology. 2010 Feb; 15(2):220-40. PMID: 20199641.
      Citations: 42     Fields:    Translation:Humans
    213. Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Clin Chest Med. 2009 Dec; 30(4):637-65, vii. PMID: 19925959.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    214. Heid IM, Huth C, Loos RJ, Kronenberg F, Adamkova V, Anand SS, Ardlie K, Biebermann H, Bjerregaard P, Boeing H, Bouchard C, Ciullo M, Cooper JA, Corella D, Dina C, Engert JC, Fisher E, Franc?s F, Froguel P, Hebebrand J, Hegele RA, Hinney A, Hoehe MR, Hu FB, Hubacek JA, Humphries SE, Hunt SC, Illig T, J?rvelin MR, Kaakinen M, Kollerits B, Krude H, Kumar J, Lange LA, Langer B, Li S, Luchner A, Lyon HN, Meyre D, Mohlke KL, Mooser V, Nebel A, Nguyen TT, Paulweber B, Perusse L, Qi L, Rankinen T, Rosskopf D, Schreiber S, Sengupta S, Sorice R, Suk A, Thorleifsson G, Thorsteinsdottir U, V?lzke H, Vimaleswaran KS, Wareham NJ, Waterworth D, Yusuf S, Lindgren C, McCarthy MI, Lange C, Hirschhorn JN, Laird N, Wichmann HE. Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design? PLoS Genet. 2009 Oct; 5(10):e1000694. PMID: 19851442; PMCID: PMC2757909.
      Citations:    
    215. Kirsten D, Gaede KI, Jafari C, Strassburg A, Greinert U, Kalsdorf B, Ernst M, Lange C, H?rster R. Antimycobacterial immune responses in patients with pulmonary sarcoidosis. Clin Respir J. 2009 Oct; 3(4):229-38. PMID: 20298409.
      Citations: 11     Fields:    Translation:HumansCells
    216. Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB, TBNET. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother. 2009 Oct; 64(4):879-83; author reply 883-4. PMID: 19651787.
      Citations:    
    217. Migliori GB, Sotgiu G, D'Arcy Richardson M, Centis R, Guenther G, Hoffmann H, Cirillo DM, Toungossova O, Kliiman K, De Lorenzo S, Spanevello A, Lange C, Tuberculosis Network European Trialsgroup. Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment. Clin Infect Dis. 2009 Jul 15; 49(2):315-6; author reply 317. PMID: 19538069.
      Citations:    
    218. Jafari C, Thijsen S, Sotgiu G, Goletti D, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C, Tuberculosis Network European Trialsgroup, Dom?nguez Ben?tez JA. Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study. Am J Respir Crit Care Med. 2009 Oct 01; 180(7):666-73. PMID: 19590020; PMCID: PMC2753791.
      Citations: 35     Fields:    Translation:HumansCellsCTClinical Trials
    219. Sarrazin H, Wilkinson KA, Andersson J, Rangaka MX, Radler L, van Veen K, Lange C, Wilkinson RJ. Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV-infected persons. J Infect Dis. 2009 Mar 01; 199(5):702-10. PMID: 19199536.
      Citations: 13     Fields:    Translation:HumansCells
    220. Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C, German TBNET Group. Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis. 2008 Nov; 14(11):1700-6. PMID: 18976552; PMCID: PMC2630755.
      Citations:    
    221. Goletti D, Carrara S, Stefania C, Butera O, Amicosante M, Ernst M, Sauzullo I, Vullo V, Cirillo D, Borroni E, Markova R, Drenska R, Dominguez J, Latorre I, Angeletti C, Navarra A, Petrosillo N, Lauria FN, Ippolito G, Migliori GB, Lange C, Girardi E. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One. 2008; 3(10):e3417. PMID: 18923709; PMCID: PMC2561073.
      Citations:    
    222. Murphy A, Weiss ST, Lange C. Screening and replication using the same data set: testing strategies for family-based studies in which all probands are affected. PLoS Genet. 2008 Sep 19; 4(9):e1000197. PMID: 18802462; PMCID: PMC2529406.
      Citations: 17     Fields:    Translation:Humans
    223. Ionita-Laza I, Perry GH, Raby BA, Klanderman B, Lee C, Laird NM, Weiss ST, Lange C. On the analysis of copy-number variations in genome-wide association studies: a translation of the family-based association test. Genet Epidemiol. 2008 Apr; 32(3):273-84. PMID: 18228561.
      Citations: 33     Fields:    Translation:Humans
    224. Migliori GB, Lange C, Girardi E, Centis R, Besozzi G, Kliiman K, Ortmann J, Matteelli A, Spanevello A, Cirillo DM, SMIRA/TBNET Study Group. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Clin Infect Dis. 2008 Mar 15; 46(6):958-9. PMID: 18288911.
      Citations:    
    225. Laird NM, Lange C. Family-based methods for linkage and association analysis. Adv Genet. 2008; 60:219-52. PMID: 18358323.
      Citations: 35     Fields:    Translation:Humans
    226. Greinert U, Hillemann D, Lange C, Richter E. [Antibiotic drug-resistant tuberculosis]. Med Klin (Munich). 2007 Dec 15; 102(12):957-66. PMID: 18075716.
      Citations:    
    227. Lange C, Hellmich B, Ernst M, Ehlers S. Rapid immunodiagnosis of tuberculosis in a woman receiving anti-TNF therapy. Nat Clin Pract Rheumatol. 2007 Sep; 3(9):528-34. PMID: 17762852.
      Citations: 6     Fields:    Translation:HumansCells
    228. Migliori GB, Ortmann J, Girardi E, Besozzi G, Lange C, Cirillo DM, Ferrarese M, De Iaco G, Gori A, Raviglione MC, SMIRA/TBNET Study Group. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis. 2007 May; 13(5):780-2. PMID: 18044040; PMCID: PMC2738462.
      Citations:    
    229. Jafari C, Ernst M, Kalsdorf B, Greinert U, Diel R, Kirsten D, Marienfeld K, Lalvani A, Lange C. Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med. 2006 Nov 01; 174(9):1048-54. PMID: 16858013.
      Citations: 44     Fields:    Translation:HumansCells
    230. Laird NM, Lange C. Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet. 2006 May; 7(5):385-94. PMID: 16619052.
      Citations: 163     Fields:    Translation:Humans
    231. Blumenthal A, Ehlers S, Buer J, Lange C, Goldmann T, Heine H, Brandt E, Reiling N, Lauber J. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood. 2006 Aug 01; 108(3):965-73. PMID: 16601243.
      Citations: 166     Fields:    Translation:HumansCells
    LANGE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (495)
    Explore
    _
    Co-Authors (13)
    Explore
    _
    Similar People (59)
    Explore
    _
    Same Department Expand Description
    Explore
    _